Hepatocellular carcinoma cell cycle: Study of Long-Evans Cinnamon rats

Hepatology

Volumn 32, Issue 4 I, 2000, Pages 711-720

  Masaki, Tsutomu ^a,c   Shiratori, Yasushi ^a   Rengifo, William ^a   Igarashi, Kouichi ^a   Matsumoto, Kouzou ^d   Nishioka, Mikio ^b   Hatanaka, Yoshio ^c   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c Takamatsu National Hospital   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE 7; CYCLIN E; CYCLIN H; UNCLASSIFIED DRUG; WEE1 KINASE;

ANIMAL TISSUE; ARTICLE; CELL CYCLE; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

EID: 0033803787     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.17705     Document Type: Article

References (49)

1. Spontaneous hepatic copper accumulation in Long-Evans cinnamon rats with hereditary hepatitis
2. D-penicillamine prevents the development of hepatitis in Long Evans Cinnamon rats with abnormal copper metabolism
3. A rat strain that spontaneously develops severe hepatic necrosis and later hepatocellular carcinoma
4. The LEC rat - An animal model for human hepatitis and hepatocellular carcinoma
5. Prevention of spontaneous hepatocellular carcinoma in Long-Evans Cinnamon rats with hereditary hepatitis by the administration of D-penicillamine
6. Cyclins and cancer II: Cyclin D and Cdk inhibitors come of age
7. Cancer cell cycles
8. Cyclins and cancer
9. How cells cycle toward cancer
10. Involvement of annexin I and annexin II in hepatocyte proliferation: Can annexin I and II be a marker for proliferative hepatocyte?
11. Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma
12. pp60(c-src) Activation in hepatocellular carcinoma of humans and LEC rats
13. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma
14. Mammalian G1 cyclins
15. G1 phase progression: Cycling on cue
16. G1 events and regulation of cell proliferation
17. The MO 15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinase (Cdks) through phosphorylation of Thr161 and its homologues
18. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
19. p40MO15 associates with a p36 subunit and phosphorylation to generate cdk-activating kinase activity in Xenopus oocytes
20. Cyclin promotes the tyrosine phosphorylation of p34cdc2 in a wee1 dependent manner
21. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
22. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma
23. Activation of mitogen-activated protein kinase extracellular signal regulated kinases in human hepatocellular carcinoma
24. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer
25. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas
26. Analysis of cyclin E and Cdk2 in ovarian cancer: Gene amplification and RNA overexpression
27. Expression and amplification of cyclin genes in human breast cancer
28. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
29. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
30. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications
31. Identification and properties of an atypical catalytic subunit (p34PSKJ3/cdk4) for mammalian D type G1 cyclins
32. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
33. Cell cycle-dependent phosphorylation of the tumor suppressor RB protein
34. Activation of the pp60(c-src) protein kinase is an early event in colonic carcinogenesis
35. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis
36. The status of multiple comparisons: Simultaneous estimation of all pair wise comparisons in one-way ANOVA designs
37. A novel cyclin encoded by a bcl1-linked candidate oncogene
38. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinoma: Their relationship to clinicopathological features
39. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/Cdk4
40. Delations of the cyclin-dependent kinase 4 inhibitor gene in multiple human cancers
41. Inactivation of p16INK4 in hepatocellular carcinoma
42. Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes
43. Amplification of a gene encoding a p53-associated protein in human sarcoma
44. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site
45. Cyclin E, a potential prognostic marker for breast cancer
46. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
47. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
48. A novel cyclin associate with MO 15/CDK7 to form the CDK-activating kinase
49. Relationships between cdc2 kinase DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard